Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × relmacabtagene autoleucel × Clear all

NCT06093841 2025-02-11

Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

Phase 2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT04812691 2023-11-22

CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse